World

Top 946 largest Companies in the Biotechnology industry in the World by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.

World Biotechnology Industry Analysis
World Top Companies World Companies Analysis

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Top Biotechnology Companies in the World as of Jul. 01, 2024

Rank Company Market Cap (USD) Country Sector Industry
331 Anika Therapeutics, Inc. $374.3 M United States US Healthcare US Biotechnology
332 Orchard Therapeutics plc $373.3 M

(Jan. 1, 2024)

 United Kingdom UK Healthcare UK Biotechnology
333 Gemini Therapeutics, Inc. $372.1 M United States US Healthcare US Biotechnology
334 IGM Biosciences, Inc. $370.7 M United States US Healthcare US Biotechnology
335 Lyell Immunopharma, Inc. $369.7 M United States US Healthcare US Biotechnology
336 Nkarta, Inc. $365.0 M United States US Healthcare US Biotechnology
337 Mycenax Biotech, Inc. $361.5 M Taiwan Taiwanese Healthcare Taiwanese Biotechnology
338 Adimmune Corp $361.3 M Taiwan Taiwanese Healthcare Taiwanese Biotechnology
339 Fate Therapeutics, Inc. $360.8 M United States US Healthcare US Biotechnology
340 Precigen, Inc. $358.4 M United States US Healthcare US Biotechnology
341 AC Immune SA $355.0 M Switzerland Swiss Healthcare Swiss Biotechnology
342 Anavex Life Sciences Corp. $354.6 M United States US Healthcare US Biotechnology
343 CARsgen Therapeutics Holdings Ltd $347.3 M China Chinese Healthcare Chinese Biotechnology
344 Silverback Therapeutics, Inc. $341.8 M United States US Healthcare US Biotechnology
345 Cabaletta Bio, Inc. $340.3 M United States US Healthcare US Biotechnology
346 TaiGen Biopharmaceuticals Holdings Ltd $336.3 M Taiwan Taiwanese Healthcare Taiwanese Biotechnology
347 Tanvex BioPharma, Inc. $334.0 M Cayman Islands Cayman Islands Healthcare Cayman Islands Biotechnology
348 Beijing Hotgen Biotech Co. Ltd $330.9 M China Chinese Healthcare Chinese Biotechnology
349 Guanhao Biotech Co.,Ltd. $329.0 M China Chinese Healthcare Chinese Biotechnology
350 Biomm SA $324.7 M Brazil Brazilian Healthcare Brazilian Biotechnology
351 Xeris Biopharma Holdings, Inc. $320.2 M United States US Healthcare US Biotechnology
352 Hansa Biopharma AB $319.2 M Sweden Swedish Healthcare Swedish Biotechnology
353 Agenus Inc. $317.7 M United States US Healthcare US Biotechnology
354 Verrica Pharmaceuticals Inc. $317.1 M United States US Healthcare US Biotechnology
355 Shandong Sito Bio-technology Co. Ltd $316.3 M China Chinese Healthcare Chinese Biotechnology
356 Cerus Corporation $314.3 M United States US Healthcare US Biotechnology
357 ADC Therapeutics SA $313.7 M Switzerland Swiss Healthcare Swiss Biotechnology
358 Atrys Health SA $313.2 M Spain Spanish Healthcare Spanish Biotechnology
359 Vanda Pharmaceuticals Inc. $311.9 M United States US Healthcare US Biotechnology
360 Adaptimmune Therapeutics plc $311.8 M United Kingdom UK Healthcare UK Biotechnology

Top Biotechnology Companies in the World as of Jul. 01, 2024

331. Anika Therapeutics, Inc.

Company Profile: Anika Therapeutics, Inc.
Market Cap (USD): $374.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

332. Orchard Therapeutics plc

Company Profile: Orchard Therapeutics plc
Market Cap (USD): $373.3 M (Jan. 1, 2024)
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

333. Gemini Therapeutics, Inc.

Company Profile: Gemini Therapeutics, Inc.
Market Cap (USD): $372.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

334. IGM Biosciences, Inc.

Company Profile: IGM Biosciences, Inc.
Market Cap (USD): $370.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

335. Lyell Immunopharma, Inc.

Company Profile: Lyell Immunopharma, Inc.
Market Cap (USD): $369.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

336. Nkarta, Inc.

Company Profile: Nkarta, Inc.
Market Cap (USD): $365.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

337. Mycenax Biotech, Inc.

Company Profile: Mycenax Biotech, Inc.
Market Cap (USD): $361.5 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

338. Adimmune Corp

Company Profile: Adimmune Corp
Market Cap (USD): $361.3 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

339. Fate Therapeutics, Inc.

Company Profile: Fate Therapeutics, Inc.
Market Cap (USD): $360.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

340. Precigen, Inc.

Company Profile: Precigen, Inc.
Market Cap (USD): $358.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

341. AC Immune SA

Company Profile: AC Immune SA
Market Cap (USD): $355.0 M
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Biotechnology

342. Anavex Life Sciences Corp.

Company Profile: Anavex Life Sciences Corp.
Market Cap (USD): $354.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

343. CARsgen Therapeutics Holdings Ltd

Company Profile: CARsgen Therapeutics Holdings Ltd
Market Cap (USD): $347.3 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

344. Silverback Therapeutics, Inc.

Company Profile: Silverback Therapeutics, Inc.
Market Cap (USD): $341.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

345. Cabaletta Bio, Inc.

Company Profile: Cabaletta Bio, Inc.
Market Cap (USD): $340.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

346. TaiGen Biopharmaceuticals Holdings Ltd

Company Profile: TaiGen Biopharmaceuticals Holdings Ltd
Market Cap (USD): $336.3 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

347. Tanvex BioPharma, Inc.

Company Profile: Tanvex BioPharma, Inc.
Market Cap (USD): $334.0 M
Country: Cayman Islands
Sector: Cayman Islands Healthcare
Industry: Cayman Islands Biotechnology

348. Beijing Hotgen Biotech Co. Ltd

Company Profile: Beijing Hotgen Biotech Co. Ltd
Market Cap (USD): $330.9 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

349. Guanhao Biotech Co.,Ltd.

Company Profile: Guanhao Biotech Co.,Ltd.
Market Cap (USD): $329.0 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

350. Biomm SA

Company Profile: Biomm SA
Market Cap (USD): $324.7 M
Country: Brazil
Sector: Brazilian Healthcare
Industry: Brazilian Biotechnology

351. Xeris Biopharma Holdings, Inc.

Company Profile: Xeris Biopharma Holdings, Inc.
Market Cap (USD): $320.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

352. Hansa Biopharma AB

Company Profile: Hansa Biopharma AB
Market Cap (USD): $319.2 M
Country: Sweden
Sector: Swedish Healthcare
Industry: Swedish Biotechnology

353. Agenus Inc.

Company Profile: Agenus Inc.
Market Cap (USD): $317.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

354. Verrica Pharmaceuticals Inc.

Company Profile: Verrica Pharmaceuticals Inc.
Market Cap (USD): $317.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

355. Shandong Sito Bio-technology Co. Ltd

Company Profile: Shandong Sito Bio-technology Co. Ltd
Market Cap (USD): $316.3 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

356. Cerus Corporation

Company Profile: Cerus Corporation
Market Cap (USD): $314.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

357. ADC Therapeutics SA

Company Profile: ADC Therapeutics SA
Market Cap (USD): $313.7 M
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Biotechnology

358. Atrys Health SA

Company Profile: Atrys Health SA
Market Cap (USD): $313.2 M
Country: Spain
Sector: Spanish Healthcare
Industry: Spanish Biotechnology

359. Vanda Pharmaceuticals Inc.

Company Profile: Vanda Pharmaceuticals Inc.
Market Cap (USD): $311.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

360. Adaptimmune Therapeutics plc

Company Profile: Adaptimmune Therapeutics plc
Market Cap (USD): $311.8 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

Top 1-year algo backtest: +265.99% - Try Disfold DeepFinance for FREE now!

Stay in touch